FTM
First Turn Management Portfolio holdings
AUM
$536M
This Quarter Return
+6.37%
1 Year Return
+36.36%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$615M
AUM Growth
+$615M
(-8%)
Cap. Flow
-$21.9M
Cap. Flow
% of AUM
-3.57%
Top 10 Holdings %
Top 10 Hldgs %
40.68%
Holding
44
New
10
Increased
7
Reduced
15
Closed
8
Top Buys
| 1 |
Insmed
INSM
|
$21.7M |
| 2 |
BPMC
Blueprint Medicines
BPMC
|
$19.9M |
| 3 |
Merus
MRUS
|
$19M |
| 4 |
Intuitive Surgical
ISRG
|
$18.6M |
| 5 |
Establishment Labs
ESTA
|
$16.8M |
Top Sells
| 1 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$31.9M |
| 2 |
Transmedics
TMDX
|
$23.7M |
| 3 |
Day One Biopharmaceuticals
DAWN
|
$21.8M |
| 4 |
Ionis Pharmaceuticals
IONS
|
$18.3M |
| 5 |
VRNA
Verona Pharma
VRNA
|
$15.7M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
argenx
ARGX
$43.6B
| $34.4M | 5.6% | 79,978 | – | – |
|
2
Sarepta Therapeutics
SRPT
$1.78B
| $28.7M | 4.67% | 181,669 -40,079 | -18% | -$6.33M |
|
3
Axsome Therapeutics
AXSM
$6.05B
| $27.1M | 4.42% | 337,246 -4,927 | -1% | -$397K |
|
4
Ascendis Pharma
ASND
$11.8B
| $25.4M | 4.14% | 186,581 +34,994 | +23% | +$4.77M |
|
5
Mirum Pharmaceuticals
MIRM
$3.71B
| $24M | 3.91% | 703,398 -255,256 | -27% | -$8.73M |
|
|
ITCI
6
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $23.8M | 3.87% | 347,343 +140,636 | +68% | +$9.63M |
|
7
Vertex Pharmaceuticals
VRTX
$100B
| $23.8M | 3.87% | 50,692 -8,140 | -14% | -$3.82M |
|
|
8
Insmed
INSM
$28.8B
| $21.7M | 3.52% | +323,360 | New | +$21.7M |
|
|
9
Transmedics
TMDX
$3.92B
| $21.1M | 3.42% | 139,780 -157,597 | -53% | -$23.7M |
|
10
Krystal Biotech
KRYS
$4.27B
| $20.1M | 3.26% | 109,222 -21,628 | -17% | -$3.97M |
|
|
BPMC
11
DELISTED
Blueprint Medicines
BPMC
| $19.9M | 3.24% | +184,901 | New | +$19.9M |
|
12
Vaxcyte
PCVX
$4B
| $19.7M | 3.2% | 260,281 | – | – |
|
13
Nuvalent
NUVL
$5.52B
| $19.1M | 3.11% | 252,276 -13,621 | -5% | -$1.03M |
|
|
14
Merus
MRUS
$4.98B
| $19M | 3.1% | +321,906 | New | +$19M |
|
|
15
Intuitive Surgical
ISRG
$170B
| $18.6M | 3.03% | +41,901 | New | +$18.6M |
|
16
Immunovant
IMVT
$2.56B
| $18.4M | 2.99% | 695,428 +182,535 | +36% | +$4.82M |
|
17
DexCom
DXCM
$29.5B
| $18.2M | 2.95% | 160,096 -32,836 | -17% | -$3.72M |
|
|
18
Establishment Labs
ESTA
$1.2B
| $16.8M | 2.73% | +369,980 | New | +$16.8M |
|
19
Crinetics Pharmaceuticals
CRNX
$2.92B
| $16.5M | 2.69% | +369,302 | New | +$16.5M |
|
20
Cytokinetics
CYTK
$4.23B
| $15.9M | 2.59% | 293,318 -137,031 | -32% | -$7.42M |
|
21
Alphatec Holdings
ATEC
$2.35B
| $14.2M | 2.31% | 1,360,410 +369,792 | +37% | +$3.86M |
|
22
IDEAYA Biosciences
IDYA
$2.15B
| $14M | 2.27% | 397,782 | – | – |
|
23
Xenon Pharmaceuticals
XENE
$2.98B
| $13.3M | 2.16% | 339,876 -340,513 | -50% | -$13.3M |
|
24
Syndax Pharmaceuticals
SNDX
$1.41B
| $13.1M | 2.14% | +640,389 | New | +$13.1M |
|
25
Revolution Medicines
RVMD
$7.1B
| $12.8M | 2.08% | +329,519 | New | +$12.8M |
|